Skip to main navigation Skip to search Skip to main content

Failure to Confirm Muscarinic Receptors on Skin Fibroblasts

  • Robert H. Lenox
  • , Robert J. Hitzemann
  • , Elliott Richelson
  • , John R. Kelsoe
  • , John R. Kelsoe
  • , J. Christian Gillin
  • , David S. Janowsky
  • , Joan Heller Brown
  • , S. Craig Risch
  • , Barry Lumkin
  • , Elliot S. Gershon
  • , N. Suzan Nadi
  • , John I. Nurnberger
  • , Wade H. Berrettini

Research output: Contribution to journal › Letter › peer-review

Abstract

To the Editor: In the July 26 issue, Nadi et al.1 reported that primary cultures of human skin fibroblasts “possess muscarinic receptors with the properties of specific binding, saturability, pharmacologic specificity, inhibition of norepinephrine-stimulated adenylate cyclase, and increased binding after incubation with an antagonist.” The authors also indicated that the fibroblasts of patients with a major affective disorder (or a relative with a history of a major or minor depressive disorder) had a significantly higher density of muscarinic binding sites as determined by the binding of the radioactive antagonist ligand [3H]quinuclidinyl benzilate ([3H]QNB) than did control subjects. They.

Original languageEnglish (US)
Pages (from-to)861-862
Number of pages2
JournalNew England Journal of Medicine
Volume312
Issue number13
DOIs
StatePublished - Mar 28 1985

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Failure to Confirm Muscarinic Receptors on Skin Fibroblasts'. Together they form a unique fingerprint.

Cite this